Government Pharmaceutical Organization
องค์การเภสัชกรรม | |
Ratchathewi, Bangkok, Thailand 13°46′00″N 100°31′43″E / 13.7668°N 100.5285°E | |
Employees | 2,812[1]: 104 |
---|---|
State enterprise executives |
|
Parent department | Ministry of Public Health |
Website | Official website |
The Government Pharmaceutical Organization (GPO) (
GPO makes and sells four categories of products: medicines;
The GPO gives Thailand significant leverage in its price negotiations with foreign drug suppliers.[4][5]
As of 2018[update], GPO's chairman is Dr Sopon Mekthon,[6] who took over from Dr Nopporn Cheanklin.[7]
Missions
GPO's mission statement contains four objectives.[8] One of them is to "To maintain price level of pharmaceutical products and medical supplies necessary for the Thai society to ensure people's accessibility." As an example, GPO will produce the antiretroviral drug efavirenz after receiving WHO approval. GPO's product costs 180 baht per bottle of thirty 600 mg tablets. The imported version retails for more than 1,000 baht per bottle. GPO will devote 2.5 percent of its manufacturing capacity to make 42 million efavirenz pills in 2018, allowing it to serve export markets as well as domestic. The Philippines alone will order about 300,000 bottles of efavirenz for 51 million baht.[9]
Compulsory licensing
The GPO is permitted to produce efavirenz and two other patented medications by having sought
Products
Sidegra
- Sidegra (Sildenafil) in 50 and 100 mg tablets.[citation needed]
Medical marijuana
GPO produces cannabinoid medicines at its factory in
The GPO led an effort to convince the military government to approve
See also
References
- ^ a b c Annual Report, 2554/2011 (2554/2011 ed.). Bangkok: Government Pharmaceutical Organization (GPO). Retrieved 5 February 2016.
- ^ "Our Factories". Government Pharmaceutical Organization (GPO). Archived from the original on 5 February 2016. Retrieved 5 February 2016.
- ^ "Company Overview of The Government Pharmaceutical Organization". Bloomberg Business. Retrieved 5 February 2016.
- ^ Fuller, Thomas (2007-04-11). "Thailand takes on drug industry, and may be winning". New York Times. Retrieved 10 May 2018.
- ^ "Thailand to sell generic Viagra drug: officials". Medical Press. AFP. September 26, 2012. Retrieved 10 May 2018.
- ^ a b "Notice from FDA quickest way to legalise marijuana, says GPO chairman". The Nation. 19 October 2018. Retrieved 19 October 2018.
- ^ "Interview: Dr. Nopporn Cheanklin – Managing Director, The Government Pharmaceutical Organization, Thailand". PharmaBoardroom. Retrieved 5 February 2016.
- ^ "Vision and Missions". Government Pharmaceutical Organization (GPO). Retrieved 3 November 2018.
- ^ Wipatayotin, Apinya (3 November 2018). "Thailand gets nod to make HIV/Aids drug". Bangkok Post. Retrieved 3 November 2018.
- ^ Wetzler, Jennryn; Mankad, Mihir; Burrowbridge, Adam (April 2009). "Timeline for US-Thailand Compulsory License Dispute (v. 3)" (PDF). infojustice.org. Program on Information Justice and Intellectual Property (PIJIP). Retrieved 4 November 2018.
- ^ "Legalisation of marijuana boosts organisations' interest in research". The Nation. 6 May 2019. Retrieved 19 August 2019.
- ^ "Thailand to start testing medical marijuana on patients". The Nation. Agence France-Presse. 8 March 2019. Retrieved 19 August 2019.
- ^ Chuwiruch, Natnicha (17 July 2018). "Thailand Wants to Have Its (Hash) Cake and Eat It Too". Bloomberg. Retrieved 17 July 2018.